Development and use of relevant hamster and mouse Sars-Cov-2 infection models to aid the design of therapeutic and prophylactic options for Covid-19. KU Leuven
IIn some patients, COVID-19 progresses from an initially mild viral syndrome to a severe and life-threatening multi-system disorder with cytokine storm. This coronavirus pandemic is putting healthcare systems worldwide under unprecedented and increasing pressure. Efficient vaccines as well antiviral (small molecules and biologicals) and anti-inflammatory drugs are urgently needed. Given the emergency, the repurposing of small molecules and/or ...